医学
风险评估
心脏病
疾病
相对风险
初级保健
儿科
内科学
家庭医学
置信区间
计算机安全
计算机科学
作者
Kathrine Stjernholm,Andrew Kerr,Katrina Poppe,Anders Elkær Jensen,Suneela Mehta,Jesper Bo Nielsen,Rod Jackson,Sue Wells
出处
期刊:Heart
[BMJ]
日期:2024-12-10
卷期号:: heartjnl-324156
被引量:1
标识
DOI:10.1136/heartjnl-2024-324156
摘要
Cardiovascular disease (CVD) preventive medications are recommended for patients at high short-term CVD risk. As most younger people with multiple raised CVD risk factors levels have low short-term risk, they could be falsely reassured to take no action. Heart age-the chronological age of a hypothetical person with the same short-term absolute CVD risk as the patient being assessed, but with an 'ideal' risk profile-is a complementary relative CVD risk metric developed to encourage these younger patients to make long-term lifestyle changes. However, clinicians sometimes use heart age to inform medication decisions. We assessed the appropriateness of this practice by comparing heart age and short-term CVD risk.
科研通智能强力驱动
Strongly Powered by AbleSci AI